+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Industrial Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Industrial Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • October 2023
  • 129 Pages
  • Global
From
Hemophilia a (Factor Viii Deficiency) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hemophilia a (Factor Viii Deficiency) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 406 Pages
  • Global
From
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 394 Pages
  • Global
From
Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 53 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Hemophilia A and B - Epidemiology Forecast to 2030 - Product Thumbnail Image

Hemophilia A and B - Epidemiology Forecast to 2030

  • Report
  • October 2021
  • 54 Pages
  • Global
From
Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Global Drug Forecast and Market Analysis to 2030

  • Report
  • April 2021
  • 122 Pages
  • Global
From
Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Epidemiology Forecast to 2030 - Product Thumbnail Image

Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Epidemiology Forecast to 2030

  • Report
  • April 2021
  • 48 Pages
  • Global
From
Hemophilia: Epidemiology Forecast to 2028 - Product Thumbnail Image

Hemophilia: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 48 Pages
  • Global
From
Ferrous Fumarate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Ferrous Fumarate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 97 Pages
  • Global
From
Vincristine Sulfate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Vincristine Sulfate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 73 Pages
  • Global
From
Integrin Beta 3 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Integrin Beta 3 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 85 Pages
  • Global
From
Argatroban Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Argatroban Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 86 Pages
  • Global
From
Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 149 Pages
  • Global
From
Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 382 Pages
  • Global
From
Hyperuricemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hyperuricemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 93 Pages
  • Global
From
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 51 Pages
  • Global
From
Iron Deficiency Anemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Iron Deficiency Anemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 96 Pages
  • Global
From
Hemochromatosis - Pipeline Review, H2 2019 - Product Thumbnail Image

Hemochromatosis - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 45 Pages
  • Global
From
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • July 2023
  • 57 Pages
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more